Company news

Upstream Bio, Inc. news in 2025

Upstream Bio, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Upstream Bio to Participate in Upcoming December Investor Conferences

November 24, 2025

Upstream Bio Reports Third Quarter 2025 Financial Results and Highlights Continued Progress

November 4, 2025

Upstream Bio to Participate in Upcoming November Investor Conferences

October 30, 2025

Upstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug’s Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society Congress

September 29, 2025

Upstream Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum

September 8, 2025

Upstream Bio Reports Positive Top-Line Results from the Phase 2 VIBRANT Trial of Verekitug for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

September 1, 2025

Upstream Bio to Host Conference Call and Webcast to Report Top-Line Data from the Phase 2 VIBRANT Trial of Verekitug in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

August 31, 2025

Upstream Bio Reports Second Quarter 2025 Financial Results and Highlights Continued Progress

August 6, 2025

Upstream Bio Announces First Patient Dosed in Phase 2 Clinical Trial of Verekitug in Chronic Obstructive Pulmonary Disease (COPD)

July 7, 2025

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor

June 15, 2025

Upstream Bio to Present Mechanistic Insights into Verekitug’s Enhanced Potency via TSLP Receptor Targeting at European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025

June 4, 2025

Upstream Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

June 3, 2025

Upstream Bio Appoints Stacy Price as Chief Technology Officer

May 19, 2025

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs

May 5, 2025

Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

March 11, 2025

Upstream Bio to Present at Upcoming March Investor Conferences

February 24, 2025

Automotive Security Leaders Must Take Immediate Action to Mitigate the Surging Cyber Threats--Upstream Report Reveals Critical Gaps

February 10, 2025

Upstream Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 5, 2025

Decks in 2025